CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-01 | Kuntz Richard Director | Grant or award · Stock Option (right to buy) | +32,162 | 32,162 | ||
| 2025-06-01 | Kellen Scott CFO & Secretary | Grant or award · Stock Option (right to buy) | +225,000 | 225,000 | ||
| 2025-06-01 | Giuffre Randall Michael Director | Grant or award · Stock Option (right to buy) | +32,162 | 32,162 | ||
| 2025-04-07 | Pilnik Richard D. Director | Option exercise | +24,000 | $2.11 | $51K | 312,995 |
| 2025-04-07 | Pilnik Richard D. Director | Option exercise · Stock Option (right to buy) | −24,000 | 0 | ||
| 2025-02-20 | O'Connor Daniel J. Director | Grant or award · Stock Option (right to buy) | +64,242 | 64,242 | ||
| 2025-02-13 | Giuffre Randall Michael Director | Option exercise | +12,000 | $2.11 | $25K | 387,412 |
| 2025-02-13 | Giuffre Randall Michael Director | Option exercise | +5,000 | $3.65 | $18K | 392,412 |
| 2025-02-13 | Giuffre Randall Michael Director | Option exercise · Stock Option (right to buy) | −12,000 | 0 | ||
| 2025-02-13 | Giuffre Randall Michael Director | Option exercise · Stock Option (right to buy) | −5,000 | 0 | ||
| 2025-01-02 | Parsons James T. Director | Grant or award | +15,917 | $5.34 | $85K | 75,854 |
| 2025-01-02 | Parsons James T. Director | Grant or award · Stock Option (right to buy) | +4,287 | 4,287 | ||
| 2025-01-02 | Giuffre Randall Michael Director | Grant or award | +10,861 | $5.34 | $58K | 375,412 |
| 2025-01-02 | Kuntz Richard Director | Grant or award | +9,925 | $5.34 | $53K | 24,210 |
| 2025-01-02 | Pilnik Richard D. Director | Grant or award | +10,393 | $5.34 | $55K | 288,995 |
| 2025-01-02 | Semba Charles Pauling Director | Grant or award | +5,290 | $5.34 | $28K | 44,608 |
| 2024-06-28 | Von Koch Thomas 10% owner | Purchase | +1,200,000 | $2.50 | $3.0M | 5,526,435 |
| 2024-06-28 | STAHLBERG JAN 10% owner | Purchase | +1,200,000 | $2.50 | $3.0M | 5,221,608 |
| 2024-06-01 | Wambeke David J. Chief Business Officer | Grant or award · Stock Option (right to buy) | +130,000 | 130,000 | ||
| 2024-06-01 | Kellen Scott CFO and Secretary | Grant or award · Stock Option (right to buy) | +130,000 | 130,000 |
Page 3 of 10 · 189 trades